Frequently Asked Questions
What exactly is the fund investing in?
Angeliki Fund is a healthcare private equity fund focused on controlling investments in memory care (dementia housing) and serious‑illness services (palliative → hospice). The strategy is to build predictable, cash‑flow healthcare platforms through operational improvement and disciplined add‑on acquisitions. The Fund is a closed‑end PE vehicle owning multiple regional platforms, not a single roll‑up entity.
Why focus on dementia care specifically?
Dementia care is a non‑cyclical, needs‑driven segment with strong demographic tailwinds, fragmented operators, and limited institutional consolidation. Memory care and palliative care both show durable demand and predictable revenue, making them suitable for a lower‑middle‑market private equity strategy.
Why combine memory care and palliative care in one fund?
The two pillars are complementary. Memory care provides real estate and operating leverage, while palliative care provides Medicare‑backed recurring revenue. Together, they support operational synergies, patient continuity, and a clean healthcare exit multiple without relying on speculative integration.
What geographies does the fund focus on?
The fund is focused mainly on Texas and Florida, where demographic growth, senior population trends, and fragmented ownership create attractive acquisition opportunities. These markets also have active strategic buyers in senior care and post‑acute healthcare.
How does this fit in my overall portfolio?
Angeliki Fund sits in the healthcare private equity / real‑asset‑backed cash‑flow sleeve of a portfolio. It complements large‑cap healthcare managers by focusing on lower‑middle‑market dementia housing and serious‑illness services with control and operational value creation.
What size companies does the fund acquire?
The fund targets platform operators with $1–10 million dollars of EBITDA, typically regional operators with 3–12 sites, followed by smaller tuck‑in acquisitions in the same markets.
Is the strategy dependent on technology?
No. Technology is used to support operations, such as staffing optimization and compliance tracking, but it is not a standalone investment thesis and does not drive underwriting.
What kind of investor is the fund a good fit for?
The fund is best suited for investors who: